SA
VBIO

Sanctuary Advisors’s Valion Bio VBIO Stock Holding History

Sanctuary Advisors’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.8K Hold
2,448
– – ﹤0.01% 2791
2026
Q1 		$54.2K Buy
+2,448
New +$62.6K ﹤0.01% 2486

Other funds holding VBIO

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Sanctuary Advisors's VBIO Position: Q2 2026 in Review

Sanctuary Advisors held its Valion Bio (VBIO) position steady in Q2 2026 at 2,448 shares worth $31.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2791.

Sanctuary Advisors first reported a position in VBIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $54.2K in Q1 2026. 11 funds tracked by Wall St. Rank hold VBIO as of Q2 2026.

  • Sanctuary Advisors held 2,448 shares of Valion Bio worth $31.8K as of Q2 2026.
  • Sanctuary Advisors left its Valion Bio share count unchanged in Q2 2026.
  • Valion Bio made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2791 holding.
  • Sanctuary Advisors first reported a position in Valion Bio in Q1 2026 and has held it in 2 quarters since.
  • Sanctuary Advisors's Valion Bio position peaked at $54.2K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Valion Bio as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.